dr Katarzyna Badowska-Rosłonek

Affiliation:

Instytut Farmaceutyczny

Participant:

V Multidyscyplinarna Konferencja Nauki o Leku

Participant:

VI Multidyscyplinarna Konferencja Nauki o Leku

Participant:

VII Multidyscyplinarna Konferencja Nauki o Leku

Participant:

VIII Multidyscyplinarna Konferencja Nauki o Leku

Participant:

IX Multidyscyplinarna Konferencja Nauki o Leku

Publications:

1. Analytical control of synthesis and determination of BR-S by HPLC
2. CHARACTERIZATION OF ARIPIPRAZOLE SOLVATE WITH ETHANOL AND POLYMORPHIC FORMS PRODUCED DURING ITS HEATING
3. Development of HPLC and GC methods for analysis of Zolmitriptan of pharmaceutical purity
4. HPLC methods for in–process control and chemical purity determination of olopatadine
5. HPLC Methods for Stress Testing of ZL-S Drug Substances
6. HPLC SEPARATION AND DETERMINATION OF ZIPRASIDONE
7. Hplc study of Cilostazol tablets: assay and release profile determination
8. Identification of degradation products of cilostazol drug substance
9. NEW SYNTHESIS OF 11-(1-PIPERAZINYL)- DIBENZO[b,f][1,4]THIAZEPINE, A CRUCIAL INTERMEDIATE IN QUETIAPINE PRODUCTION.
10. Optimization of BR-8 synthesis
11. Optimization of AR-3 synthesis
12. ¹H AND ¹³C NMR DATA FOR INDOLO[2,3-b]QUINOLINES - AMINOGLYCOSIDE HYBRIDS, A NOVEL POTENT ANTICANCER DRUG FAMILY .
13. SYNTHESIS OF GLIMEPIRIDE - CRYSTAL STRUCTURE ANALYSIS STEP BY STEP
14. The cytotoxic activity of glycosides of indolo[2,3-b]quinoline derivatives.
15. THE CYTOTOXIC GLYCOSIDES OF INDOLO[2,3-B]QUINOLINE DERIVATIVES. IN VITRO AND IN VIVO STUDIES
16. Validation of HPLC methods for analyzing the chemical purity of cilostazol
17. Zolmitriptan synthesis and in-process control by HPLC methods